                               SEQUENCE LISTING

<110> INSIDEOUTBIO, INC.
 
<120> METHODS AND COMPOSITIONS FOR TARGETED DELIVERY OF NUCLEIC ACID 
      THERAPEUTICS

<130> 0371.0008WO1

<140>
<141>

<150> 62/947,563
<151> 2019-12-13

<160> 6     

<170> PatentIn version 3.5

<210> 1
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 1
tgtgggggtg gacgggccgg gtaga                                             25


<210> 2
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 2
gggttatatt actcggccgg tgtaa                                             25


<210> 3
<211> 50
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 3
ctcgtccccc aggcatagat actccgcccc gtcacggatc ctctagagca                  50


<210> 4
<211> 47
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 4
ccccccgggg cgggccgggg gcggggtccc ggcggggcgg agccatg                     47


<210> 5
<211> 39
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 5
gggaggacga ugcggaucag ccauguuuac gucacuccu                              39


<210> 6
<211> 40
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 6
cggccacaga augaaaaacc ucaucgaugu ugcauaguug                             40


